Stem Cells Spin S.A.

Equities

SCS

PLSTCLS00013

Biotechnology & Medical Research

End-of-day quote Warsaw S.E. Other stock markets 06:00:00 2024-06-25 pm EDT			5-day change	1st Jan Change
0.43 ^PLN	-8.12%		-8.12%	+26.47%

May. 15	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Feb. 14	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024

May 15, 2024 at 09:15 am EDT

Stem Cells Spin S.A. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported revenue was PLN 0.001497 million compared to PLN 0.051448 million a year ago. Net loss was PLN 0.128547 million compared to PLN 0.078444 million a year ago.

Latest news about Stem Cells Spin S.A.

Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 15	CI
Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 14	CI
Stem Cells Spin S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 14	CI
Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Stem Cells Spin S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-14	CI
Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-14	CI
Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-16	CI
Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	22-02-14	CI
Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-17	CI
Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	21-02-15	CI
Astoria Capital Spólka Akcyjna sold 9.28% stake in Stem Cells Spin Spólka Akcyjna.	15-01-22	CI

Chart Stem Cells Spin S.A.

Duration

Period

More charts

Company Profile

Stem Cells Spin SA is a Poland-based company. It is primarily engaged in biotechnology research. The Company is focused on development, production, marketing and sale of natural regenerative products for the dermocosmetic and veterinary care markets.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
STEM CELLS SPIN S.A.	+26.47%	4.4M
MODERNA, INC.	+23.13%	46.93B
LONZA GROUP AG	+37.07%	39.08B
IQVIA HOLDINGS INC.	-8.73%	38.48B
ALNYLAM PHARMACEUTICALS, INC.	+28.09%	31.01B
CELLTRION, INC.	-12.26%	26.14B
ICON PUBLIC LIMITED COMPANY	+10.57%	25.88B
MEDPACE HOLDINGS, INC.	+32.23%	12.53B
BIO-TECHNE CORPORATION	-6.56%	11.36B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-12.56%	10.65B

Other Biotechnology & Medical Research